Reply
- PMID: 33586355
- DOI: 10.1002/art.41689
Reply
Comment on
-
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2.Arthritis Rheumatol. 2021 Apr;73(4):e13-e29. doi: 10.1002/art.41616. Epub 2021 Feb 15. Arthritis Rheumatol. 2021. PMID: 33277976 Free PMC article.
-
Prophylactic Anticoagulation Therapy: Comment on the Article by Henderson et al.Arthritis Rheumatol. 2021 Jul;73(7):1341-1342. doi: 10.1002/art.41690. Epub 2021 Jun 1. Arthritis Rheumatol. 2021. PMID: 33586369 No abstract available.
References
-
- Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, et al. Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc 2016;5:e003289.
-
- Giglia TM, Massicotte MP, Tweddell JS, Barst RJ, Bauman M, Erickson CC, et al. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation 2013;128:2622-703.
-
- Elias MD, McCrindle BW, Larios G, Choueiter NF, Dahdah N, Harahsheh AS, et al. Management of multisystem inflammatory syndrome in children associated with COVID-19: a survey from the International Kawasaki Disease Registry. CJC Open 2020;2:632-40.
-
- Diorio C, McNerney KO, Lambert M, Paessler M, Anderson EM, Henrickson SE, et al. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv 2020;4:6051-63.
-
- Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MB, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 2020;383:334-46.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
